A novel compound ARN-3236 inhibits salt-inducible kinase 2 and sensitizes ovarian cancer cell lines and xenografts to paclitaxel. by Zhou, J, Alfraidi, A, Zhang, S, Santiago-O'Farrill, J, Yerramreddy Reddy, V, Alsaadi, A, Ahmed, A, Yang, H, Liu, J, Mao, W, Wang, Y, Takemori, H, Vankayalapati, H, Lu, Z, Bast, R